Peran Mutasi Gen BCR-Abl pada Perjalanan Klinis Pasien Leukemia Granulositik Kronik (LGK): Kaitannya dengan Aspek Terapi Imatinib Mesylate (IM) = The Role of BCR-Abl Gene Mutation in Clinical Course of Chronic Myeloid Leukemia Patients (CML): Relation to Aspects of Imatinib Mesylate Therapy (IM)

Penemuan inhibitor BCR-ABL terbarukan menggunakan penapisan virtual berbasis farmakofor dan simulasi dinamika molekul dalam terapi obat leukemia = Discovery of a novel BCR-ABL inhibitor using pharmacophore based virtual screening and molecular dynamics simulation in leukemia drug therapy

Hubungan Mutasi T315I Gen ABL1 dengan Pencapaian Major Molecular Response (MMR) pada Pasien Leukemia Granulositik Kronik Fase Kronik yang Mendapat Imatinib = Association between T315I Mutation in ABL1 Gene to the Achievement of Major Molecular Response (MMR) in Chronic Phase of Chronic Myeloid Leukemia Patients Treated with Imatinib

Hubungan ekspresi gen stat5a dan stat5b dengan pencapaian major molecular response (MMR) pada pasien leukemia granulositik kronik yang mendapat imatinib = Expression of stat5a and stat5b and its relation to achievement of major molecular response in patient with chronic phase chronic myeloid leukemia on imatinib treatment

Perbandingan dan hubungan gambaran klinis dan laboratorium hematologis antara leukemia granulositik kronik ph/bcr-abl dengan leukemia granulositik kronik bentuk kelainan ph/bcr-abl lainnya = Comparison and association of clinical features and hematological laboratories between ph/bcr-abl chronic myeloid leukemia and other type of ph/bcr-abl chronic myeloid leukemia